https://stock.noler.com/us/stock/rapt-therapeutics-inc https://stock.noler.com/us/stock/rapt-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/rapt-therapeutics-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/rapt-therapeutics-inc/accrual-payments https://stock.noler.com/us/stock/rapt-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/rapt-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/rapt-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/rapt-therapeutics-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/rapt-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/rapt-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/rapt-therapeutics-inc/aoci https://stock.noler.com/us/stock/rapt-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/rapt-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/rapt-therapeutics-inc/available-for-sale-debt-allowance-for-credit-loss https://stock.noler.com/us/stock/rapt-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/rapt-therapeutics-inc/available-for-sale-debt-amortized-cost-current https://stock.noler.com/us/stock/rapt-therapeutics-inc/available-for-sale-debt-maturities-after-one-through-five-years-fair-value https://stock.noler.com/us/stock/rapt-therapeutics-inc/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/rapt-therapeutics-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/rapt-therapeutics-inc/available-for-sale-debt-unrealized-loss-position https://stock.noler.com/us/stock/rapt-therapeutics-inc/available-for-sale-securities https://stock.noler.com/us/stock/rapt-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/rapt-therapeutics-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/rapt-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/rapt-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/rapt-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/rapt-therapeutics-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/rapt-therapeutics-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/rapt-therapeutics-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/rapt-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/rapt-therapeutics-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/rapt-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/rapt-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/rapt-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/rapt-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/rapt-therapeutics-inc/current-assets https://stock.noler.com/us/stock/rapt-therapeutics-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/rapt-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/rapt-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/rapt-therapeutics-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/rapt-therapeutics-inc/deferred-revenue https://stock.noler.com/us/stock/rapt-therapeutics-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/rapt-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/rapt-therapeutics-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/rapt-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/rapt-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/rapt-therapeutics-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/rapt-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/rapt-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/rapt-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/rapt-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/rapt-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/rapt-therapeutics-inc/dividends-common-stock https://stock.noler.com/us/stock/rapt-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/rapt-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/rapt-therapeutics-inc/eps https://stock.noler.com/us/stock/rapt-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/rapt-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/rapt-therapeutics-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/rapt-therapeutics-inc/foreign-pretax-income https://stock.noler.com/us/stock/rapt-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/rapt-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/rapt-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/rapt-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/rapt-therapeutics-inc/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/rapt-therapeutics-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/rapt-therapeutics-inc/income-loss-from-per-basic-share https://stock.noler.com/us/stock/rapt-therapeutics-inc/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/rapt-therapeutics-inc/income-tax https://stock.noler.com/us/stock/rapt-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/rapt-therapeutics-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/rapt-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/rapt-therapeutics-inc/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/rapt-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/rapt-therapeutics-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/rapt-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/rapt-therapeutics-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/rapt-therapeutics-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/rapt-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/rapt-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/rapt-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/rapt-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/rapt-therapeutics-inc/investment-income-amortization-of-discount https://stock.noler.com/us/stock/rapt-therapeutics-inc/investment-income-amortization-of-premium https://stock.noler.com/us/stock/rapt-therapeutics-inc/investment-income-net-amortization-of-discount-and-premium https://stock.noler.com/us/stock/rapt-therapeutics-inc/lease-cost https://stock.noler.com/us/stock/rapt-therapeutics-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/rapt-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/rapt-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/rapt-therapeutics-inc/marketable-securities-current https://stock.noler.com/us/stock/rapt-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/rapt-therapeutics-inc/net-income https://stock.noler.com/us/stock/rapt-therapeutics-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/rapt-therapeutics-inc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/rapt-therapeutics-inc/oci-net-of-tax https://stock.noler.com/us/stock/rapt-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/rapt-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/rapt-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/rapt-therapeutics-inc/operating-income https://stock.noler.com/us/stock/rapt-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/rapt-therapeutics-inc/operating-lease-expense https://stock.noler.com/us/stock/rapt-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/rapt-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/rapt-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/rapt-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/rapt-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/rapt-therapeutics-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/rapt-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/rapt-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/rapt-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/rapt-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/rapt-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/rapt-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/rapt-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/rapt-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/rapt-therapeutics-inc/other-income https://stock.noler.com/us/stock/rapt-therapeutics-inc/other-noncash-income-expense https://stock.noler.com/us/stock/rapt-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/rapt-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/rapt-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/rapt-therapeutics-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/rapt-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/rapt-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/rapt-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/rapt-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/rapt-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/rapt-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/rapt-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/rapt-therapeutics-inc/pretax-income-domestic https://stock.noler.com/us/stock/rapt-therapeutics-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/rapt-therapeutics-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/rapt-therapeutics-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/rapt-therapeutics-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/rapt-therapeutics-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/rapt-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/rapt-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/rapt-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/rapt-therapeutics-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/rapt-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/rapt-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/rapt-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/rapt-therapeutics-inc/public-float https://stock.noler.com/us/stock/rapt-therapeutics-inc/receivable-from-officers-and-directors-for-issuance-of-capital-stock https://stock.noler.com/us/stock/rapt-therapeutics-inc/receivables-net-current https://stock.noler.com/us/stock/rapt-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/rapt-therapeutics-inc/restructuring-and-related-cost-number-of-positions-eliminated https://stock.noler.com/us/stock/rapt-therapeutics-inc/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/rapt-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/rapt-therapeutics-inc/revenue https://stock.noler.com/us/stock/rapt-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/rapt-therapeutics-inc/severance-costs https://stock.noler.com/us/stock/rapt-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/rapt-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/rapt-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/rapt-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-payments https://stock.noler.com/us/stock/rapt-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/rapt-therapeutics-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/rapt-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/rapt-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/rapt-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/rapt-therapeutics-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/rapt-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/rapt-therapeutics-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/rapt-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/rapt-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/rapt-therapeutics-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/rapt-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/rapt-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/rapt-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/rapt-therapeutics-inc/tax-rate-reconciliation-gilti-percent https://stock.noler.com/us/stock/rapt-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/rapt-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/rapt-therapeutics-inc/tax-rate-reconciliation-tax-credits-foreign https://stock.noler.com/us/stock/rapt-therapeutics-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/rapt-therapeutics-inc/tax-rate-reconciliation-tax-exempt-income https://stock.noler.com/us/stock/rapt-therapeutics-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/rapt-therapeutics-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/rapt-therapeutics-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/rapt-therapeutics-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/rapt-therapeutics-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/rapt-therapeutics-inc/temporary-equity-shares-issued-value-new-issues https://stock.noler.com/us/stock/rapt-therapeutics-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/rapt-therapeutics-inc/tenant-improvements https://stock.noler.com/us/stock/rapt-therapeutics-inc/total-assets https://stock.noler.com/us/stock/rapt-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/rapt-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/rapt-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/rapt-therapeutics-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/rapt-therapeutics-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/rapt-therapeutics-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/rapt-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/rapt-therapeutics-inc/variable-lease-cost https://stock.noler.com/us/stock/rapt-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/rapt-therapeutics-inc/weighted-average-number-of-shares-common-stock-subject-to-repurchase-or-cancellation https://stock.noler.com/us/stock/rapt-therapeutics-inc/weighted-average-number-of-shares-issued-basic https://stock.noler.com/us/stock/rapt-therapeutics-inc/workers-compensation-liability-current